| Study (year) | Type of cancer | Sample sizes | Interventions | Acupuncture point selection | Session frequency and duration | Main outcomes and assessment of pain | T | C | T | C |
| Wang (2018) [10] | Various | 35 | 35 | AT + C | Drug (three-step analgesic ladder) | LI4, LR3, and Ashi point | 30 min qd 6 weeks | Response rate, NRS, and side effect rate |
| Wang (2016) [11] | Lung cancer | 30 | 30 | EA + C | Oxycodone sustained-release tablets | LI4, PC6, ST36, and SP6 | 30 min qd 14 days | Response rate, NRS, side effect rate, burst pain, onset time, and DOR |
| Zhong (2016) [12] | Various | 30 | 30 | FA + C | Morphine sulfate sustained-release tablets | Ashi point | Once a day 14 days | Response rate, QOL, and burst pain |
| Mi (2010) [13] | Gastric cancer | 32 | 30 | FN + AT + C | Drug (three-step analgesic ladder) | FN: BL21, BL18, and BL17. AT: CV12, ST25, and St36 | 30 min qod 4 weeks | Response rate and side effect rate |
| Bai (2019) [14] | Various | 50 | 50 | FN + C | Drug (three-step analgesic ladder) | Ashi point, ST36, and SP6 | qod 14 days | Response rate, NRS, and side effect rate |
| Liu (2018) [15] | Various | 72 | 75 | TEAS + C | Drug (three-step analgesic ladder) | LI4, PC6, ST36, and SP6 | 30 min bid 3 weeks | Response rate, BPI-S, KPS, and side effect rate |
| Liu (2011) [16] | Liver cancer | 30 | 30 | AT + C | Tramadol hydrochloride sustained-release tablets | SP4, PC6, GB41, TE5, SI3, BL62, LU7, KI6, LR3, and LR14 | qd 14 days | Response rate, NRS, QOL, side effect rate, onset time, and DOR |
| Fu (2019) [17] | Various | 16/16 | 16 | AT + C | Morphine hydrochloride sustained-release tablets | PC6 and SP6 | 1 h qd | Response rate, NRS, KPS, side effect rate, burst pain, onset time, and DOR | | | | | WA + C | | |
| Wu (2019) [18] | Various | 30 | 30 | WA + C | Drug (three-step analgesic ladder) | Based on syndrome differentiation and disease differentiation | 12 h qd 10 days | Response rate, VAS, burst pain, and side effect rate |
| Dong (2018) [19] | Various | 60 | 60 | WA + C | Drug (three-step analgesic ladder) | Based on syndrome differentiation and disease differentiation | 10–12 h qd 7 days | Response rate, NRS, QLQ-C30, and side effect rate |
| Sun (2016) [20] | Various | 30 | 30 | AT + C | Oxycodone | LI4, PC6, ST36, SP6, Ashi point, and others | 30 min qd 14 days | Response rate, NRS, KPS, QOL, and side effect rate |
| Zhang (2014) [21] | Various | 30 | 30 | AT + C | Drug (three-step analgesic ladder) | LI4 and ST36. Lung cancer: PC6 and LU6. Liver cancer: GB34, LR6, and LR3. Colorectal cancer: PC6, CV12, and TE6 | 30 min qd 7 days | Response rate, QOL, side effect rate, onset time, and DOR |
| Hui (2019) [22] | Various | 40 | 40 | AT + C | Drug (three-step analgesic ladder) | Ashi point, LI4, GV14, BL11, GB34, and LR3 | 30 min qd 14 days | Response rate, side effect rate, onset time, and DOR |
| Tan (2012) [23] | Various | 106 | 101 | AT + C | Drug (three-step analgesic ladder) | LI4 and PC6. Lung cancer: LU6. Liver cancer: GB34 and LR6. Colorectal cancer: CV12, ST36, and TE6 | 0.5–1 h qd 3 weeks | Response rate and side effect rate |
| Fan (2017) [24] | Lung cancer | 35 | 34 | AT + C | Drug (three-step analgesic ladder) | PC6, LI4, ST36, GB34, and SP6 | 20 min qd 20 days | Response rate, NRS, onset time, and DOR |
| Jiang (2016) [25] | Various | 25 | 25 | AT + C | Drug (three-step analgesic ladder) | Ashi point, LR3, and LI4 | 30 min qd 7 days | Response rate and NRS |
| Li (2017) [26] | Gastric cancer | 30 | 30 | AT + C | Drug (three-step analgesic ladder) | ST36, LR3, and LI4 | 30 min qd 7 days | Response rate, NRS, QOL, and side effect rate |
| Huang (2018) [27] | Various | 31 | 31 | AT + C | Drug (three-step analgesic ladder) | PC6. Lung cancer: LI4, LU4, LU6, and ST36. Liver cancer: GB34 and LR3. Breast cancer: LI4, STI8, and CV9. Gastric cancer: CV12, ST36, and TE6 | 30 min qd 7 days | Response rate |
| Peng (2012) [28] | Various | 23 | 24 | EA + C | Drug (three-step analgesic ladder) | LI4, PC6, ST36, and SP6 | 30 min qd 7 days | Response rate, onset time, and DOR |
|
|
T: treatment group, C: control group, AT: acupuncture, EA: electroacupuncture, FA: floating acupuncture, FN: fire needle, WA: wrist-ankle acupuncture, DOR: duration of response, NRS: numerical rating scale, BPI-S: brief pain inventory-severity, QOL: quality of life, and KPS: Karnofsky performance status.
|